Thromb Haemost 2002; 87(04): 706-711
DOI: 10.1055/s-0037-1613069
Review Article
Schattauer GmbH

A 28-kDa Glycoprotein Functions as a Platelet Ligand for P-selectin (CD62P)[*]

Ling Li
2   Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China
,
Kai-Xian Qian
1   School of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China
,
Jian-Guo Geng
2   Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China
› Author Affiliations
Further Information

Publication History

Received 07 October 2001

Accepted after resubmission 14 December 2001

Publication Date:
27 December 2017 (online)

Summary

P-selectin (CD62P) is expressed on activated platelets and on stimulated endothelial cells. It interacts with P-selectin glycoprotein ligand-1 (PSGL-1; CD162) for adhesion of activated platelets on leukocytes and for rolling of leukocytes on stimulated endothelial cells. Recently, resting and activated platelets have been shown to roll on endothelial P-selectin, indicating that platelets express (a) ligand(s) for P-selectin. Here we show that P-selectin specifically precipitated one 28-kDa glycoprotein from the whole cell lysates and the membrane lysates of human platelets in a Ca2+-dependent manner. Further, the purified 28-kDa molecule could inhibit the binding of P-selectin to human resting and activated platelets. In contrast, KPL1 (a leukocyte adhesion blocking MoAb to PSGL-1) did not neutralize the binding of P-selectin to human platelets, even though it abolished the binding of P-selectin to human promyeloid HL-60 cells. Our results thus indicate that the 28-kDa glycoprotein may function as an important platelet ligand for P-selectin.

*Supported by grants from Chinese Academy of Sciences (KSCX2-2-02), National Natural Science Foundation of China (39925015, 30130090), Special Funds forMajor State Basic Research of China (Grant G1999053907)


 
  • References

  • 1 Springer TA. Traffic signals for lymphocyte recruitment and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-14.
  • 2 McEver RP, Moore KL, Cummings RD. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 1995; 270: 11025-8.
  • 3 Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999; 79: 181-213.
  • 4 Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyteplatelet interaction. Thromb Haemost 1999; 81: 1-7.
  • 5 Geng J-G. Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies. Cell Res 2001; 11: 85-8.
  • 6 Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993; 74: 541-54.
  • 7 Subramaniam M, Frenette PS, Saffaripour S, Johnson RC, Hynes RO, Wagner DD. Defects in hemostasis in P-selectin-deficient mice. Blood 1996; 87: 1238-42.
  • 8 Yang J, Hirata T, Croce K, Merrill-Skoloff G, Tchernychev B, Williams E, Flaumenhaft R, Furie BC, Furie B. Targeted gene disruption demonstrates that P-selectin glycoprotein ligand-1 (PSGL-1) is required for P-selectinmediated but not E-selectin-mediated neutrophil rolling and migration. J Exp Med 1999; 190: 1769-82.
  • 9 Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92: 7450-4.
  • 10 Frenette PS, Moyna C, Hartwell DW, Lowe JB, Hynes RO, Wagner DD. Platelet-endothelial interactions in inflamed mesenteric venules. Blood 1998; 91: 1318-24.
  • 11 Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999; 190: 803-14.
  • 12 Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD. P-selectin glycoprotein ligand 1 (PSGE-1) is expressed on platelets and can mediate platelet endothelial interactions in vivo . J Exp Med 2000; 291: 1413-22.
  • 13 Asa D, Raycroft L, Ma L, Aeed PA, Kaytes PS, Elhammer ÅP, Geng J-G. The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins. J Biol Chem 1995; 270: 11662-70.
  • 14 Kaytes PK, Geng J-G. P-selectin mediates adhesion of the human melanoma cell line NKI-4: Identification of glycoprotein ligands. Biochemistry 1998; 37: 10514-21.
  • 15 Ma L, Raycroft L, Asa D, Anderson DC, Geng J-G. A sialoglycoprotein from human leukocytes functions as a ligand for P-selectin. J Biol Chem 1994; 269: 27739-46.
  • 16 Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, Zimmerman GA, McEver RP. Rapid neutrophil adhesion to activated endothelium mediated by GMP140. Nature 1990; 343: 757-60.
  • 17 Snapp KR, Ding H, Atkins K, Warnke R, Luscinskas FW, Kansas GS. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin. Blood 1998; 91: 154-64.
  • 18 Ma Y-Q, Geng J-G. Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow. J Immunol 2000; 165: 558-65.
  • 19 Palabrica T, Lobb R, Furie BC, Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848-51.
  • 20 Toombs CF, DeGraaf GL, Martin JP, Geng J-G, Anderson DC, Shebuski RJ. Inhibition of P-selectin with the GA6 monoclonal antibody accelerates pharmacological thrombolysis in a primate model of arterial thrombosis. J Pharmacol Exp Ther 1995; 275: 941-9.
  • 21 Celi A, Pellegrini G, Lorenzet R, Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 1994; 91: 8767-71.
  • 22 Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, Hulin MS, Kadell AM, Wilke CA, Brown SL, Wrobleski SK, Burdick MD, Anderson DC, Greenfield LJ. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997; 25: 816-27.
  • 23 Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31: 352-8.
  • 24 Michael M, Perumal T. P-selectin Expression on Platelets Determines Size and Stability of Platelet Aggregates. Circulation 2000; 102: 1931-6.